NIOX Group Plc (NIOX.L)
- Previous Close
66.40 - Open
68.00 - Bid 66.60 x --
- Ask 67.80 x --
- Day's Range
66.20 - 68.00 - 52 Week Range
53.40 - 80.00 - Volume
246,398 - Avg. Volume
1,343,471 - Market Cap (intraday)
265.772M - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
66.78 - EPS (TTM)
0.01 - Earnings Date Apr 1, 2025
- Forward Dividend & Yield 0.01 (1.88%)
- Ex-Dividend Date May 15, 2025
- 1y Target Est
78.80
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
investors.niox.comRecent News: NIOX.L
View MorePerformance Overview: NIOX.L
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NIOX.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NIOX.L
View MoreValuation Measures
Market Cap
264.26M
Enterprise Value
254.86M
Trailing P/E
87.37
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.12
Price/Book (mrq)
4.44
Enterprise Value/Revenue
6.10
Enterprise Value/EBITDA
21.06
Financial Highlights
Profitability and Income Statement
Profit Margin
8.85%
Return on Assets (ttm)
6.02%
Return on Equity (ttm)
4.74%
Revenue (ttm)
41.8M
Net Income Avi to Common (ttm)
3.4M
Diluted EPS (ttm)
0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
10.9M
Total Debt/Equity (mrq)
2.52%
Levered Free Cash Flow (ttm)
14.05M